For Authors

Publication Ethics and Publication Malpractice Statement

“International Journal of Biomedicine” (IJBM) endorses and behaves in accordance with the codes of conduct and international standards established by the Committee on Publication Ethics (COPE). IJBM publishes peer-reviewed articles on the topics of basic, applied, and translational research on biology and medicine.

Editorial Procedures

IJBM’s editorial procedures are guided by the COPE Code of Conduct for Journal Editors. The editor also may be guided by the policies of the journal’s editorial board. Manuscripts are evaluated for their content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. IJBM is committed to following best practices on ethical matters, errors, and retractions, and to provide legal review if necessary.


The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author and reviewers, other editorial advisers, as appropriate.

Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. All authors must disclose any financial or other relations that could lead to a conflict of interest. If a potential conflict exists, its nature should be stated for each author. When there is a stated potential conflict of interest a footnote will be added indicating the author's equity interest in or other affiliation with the identified commercial firms. All sources of financial support for the study should be cited, including federal or state agencies, nonprofit organizations, and pharmaceutical or other commercial sources. Acknowledgment of those who contributed to the research or preparation of the paper should follow the text.

Review Process

IJBM reviews the manuscript for appropriateness and notifies the corresponding author whether it is under consideration for publication. Articles under such consideration are sent to expert peer reviewers selected by the editor. Reviews should be conducted objectively. Reviewers should express their views clearly with supporting arguments. IJBM reserves the right to edit text for clarity, style, and length. Final drafts are sent to authors for review before publication. If the reviewers recommend extensive revisions or have question, authors may be asked to revise their manuscript and then resubmit the article. Manuscripts sent for review are the private property of the authors. Reviewers not are allowed to make copies of the manuscript for their files. Reviewers should return or destroy copies of manuscripts after submitting reviews. Accepted manuscripts become the sole property of the IJBM and may not be published elsewhere without the consent of the IJBM.


Research papers are published in print and online 4 to 8 weeks after acceptance. The official publication date of these papers is the date that they are posted online. Authors whose papers are published in the current issue will receive a free Certificate of Publication in recognition of his or her contribution to the biomedical science.

Duties of Authors

IJBM accepts manuscripts that have not been published elsewhere and are not under consideration for publication by other print or electronic media. Authors must present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. The authors should ensure that they have written entirely original works, and if the authors have used the work of others that this has been appropriately cited. Manuscript should conform to the Uniform Requirements for Manuscript Submitted to Biomedical Journals, developed by the International Committee of Medical Journal Editors and available at Please review section “For Authors”.

Ethical Considerations in the Conduct and Reporting of Research: Protection of Human Subjects and Animals in Research

Studies involving human subjects or tissues must adhere to the Declaration of Helsinki and Title 45, US Code of Federal Regulations, Part 46, Protection of Human Subjects, and must have received approval of the appropriate institutional committee charged with oversight of human studies. Informed consent must be obtained. All research studies involving animals must have been conducted following animal welfare guidelines such as the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, or equivalent documents.

Copyright & Self-archiving

IJBM articles are published under an IMRDC user license. Authors grant to the Journal an exclusive right to publish his/her article on Journal’s online platform, the right to share his/her article in all formats so his/her research is widely distributed after publication  using the latest technology. Articles published under an IMRDC user license are protected by copyright and may be used for non-commercial purposes. A copy of the full text of each Open Access article is archived in an online repository separate from the journal. The authors can also self-archive the final publisher's version/PDF on personal website, departmental website, institutional repository with a link to publisher version.
Users may access, download, copy, translate, text and data mine (but may not redistribute, display or adapt) the articles for non-commercial purposes provided that users cite the article using an appropriate bibliographic citation (i.e. author(s), journal, article title, volume, issue, page numbers, DOI and the link to the definitive published PDF version on

IJBM is committed to working closely with research organizations and institutions in line with CORE’s advice on Cooperation between Research Institutions and Journals on Research Integrity Cases.